Back to HomeBeta

ICD-10 Coding for Secondary Lung Cancer(C78.00, C78.01, C78.02)

Complete ICD-10-CM coding and documentation guide for Secondary Lung Cancer. Includes clinical validation requirements, documentation requirements, and coding pitfalls.

Also known as:

Metastatic Lung CancerLung Metastases

Related ICD-10 Code Ranges

Complete code families applicable to Secondary Lung Cancer

C78.00-C78.02Primary Range

Secondary malignant neoplasm of lung

Used for coding metastases to the lung from another primary site.

Secondary malignant neoplasm of other sites

Used for coding metastases to sites other than the lung.

Malignant neoplasm, unspecified

Used when the primary site of the cancer is unknown.

Code Comparison: When to Use Each Code

Compare key differences between these codes to ensure accurate selection

CodeDescriptionWhen to UseKey Documentation
C78.00Secondary malignant neoplasm of unspecified lungUse when metastasis to the lung is confirmed but laterality is not specified.
  • Imaging showing lung lesion
  • Biopsy confirming metastasis
C78.01Secondary malignant neoplasm of right lungUse when metastasis to the right lung is confirmed.
  • Imaging showing lesion in right lung
  • Biopsy confirming metastasis
C78.02Secondary malignant neoplasm of left lungUse when metastasis to the left lung is confirmed.
  • Imaging showing lesion in left lung
  • Biopsy confirming metastasis

Clinical Decision Support

Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.

Key Information: ICD-10 code for secondary lung cancer

Essential facts and insights about Secondary Lung Cancer

The ICD-10 codes for secondary lung cancer are C78.00-C78.02, used based on laterality.

Primary ICD-10-CM Codes for secondary lung cancer

Secondary malignant neoplasm of unspecified lung
Billable Code

Decision Criteria

clinical Criteria

  • Confirmed metastasis to lung via imaging or biopsy.

documentation Criteria

  • Documentation must specify 'metastatic to lung'.

Applicable To

  • Metastatic cancer to lung, unspecified

Excludes

  • Primary lung cancer (C34.xx)

Clinical Validation Requirements

  • Imaging showing lung lesion
  • Biopsy confirming metastasis

Code-Specific Risks

  • Risk of unspecified laterality leading to reduced specificity.

Coding Notes

  • Ensure documentation specifies 'metastatic to lung' and not primary lung cancer.

Ancillary Codes

Additional codes that should be used in conjunction with the main diagnosis codes when applicable.

Malignant neoplasm, unspecified

C80.1
Use when the primary site is unknown.

Differential Codes

Alternative codes to consider when ruling out similar conditions to the primary diagnosis.

Primary malignant neoplasm of bronchus and lung

C34.xx
Use C34.xx for primary lung cancer, not for metastases.

Malignant neoplasm of right bronchus and lung, unspecified

C34.91
Use C34.91 for primary lung cancer, not for metastases.

Malignant neoplasm of left bronchus and lung, unspecified

C34.92
Use C34.92 for primary lung cancer, not for metastases.

Documentation & Coding Risks

Avoid these common documentation and coding issues when documenting Secondary Lung Cancer to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code C78.00.

Impact

Clinical: Impacts treatment planning and monitoring., Regulatory: Non-compliance with coding standards., Financial: Potential for denied claims due to unspecified codes.

Mitigation Strategy

Always document laterality for lung metastases., Use templates that prompt for complete information.

Impact

Reimbursement: Incorrect coding can lead to denied claims., Compliance: Non-compliance with ICD-10 coding guidelines., Data Quality: Inaccurate data on cancer prevalence and treatment.

Mitigation Strategy

Use C78.0x codes for metastases to the lung.

Impact

Leads to incorrect DRG assignment and reimbursement issues.

Mitigation Strategy

Train coders on proper sequencing rules and documentation requirements.

Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.

Frequently Asked Questions

Common questions about ICD-10 coding for Secondary Lung Cancer, with expert answers to help guide accurate code selection and documentation.

Documentation Templates for Secondary Lung Cancer

Use these documentation templates to ensure complete and accurate documentation for Secondary Lung Cancer. These templates include all required elements for proper coding and billing.

Metastatic Lung Cancer Documentation

Specialty: Oncology

Required Elements

  • Primary cancer site
  • Metastatic sites
  • Imaging and biopsy results
  • Treatment plan

Example Documentation

Patient with metastatic breast cancer to the right lung, confirmed via CT-guided biopsy. Treatment plan includes chemotherapy targeting both primary and metastatic sites.

Examples: Poor vs. Good Documentation

Poor Documentation Example
Lung mets, chemo planned.
Good Documentation Example
Metastatic pancreatic adenocarcinoma (C25.9) to right lung (C78.01), confirmed via EBUS-FNA. Plan: FOLFIRINOX targeting primary + lung lesion.
Explanation
The good example specifies the primary site, confirms metastasis, and details the treatment plan.

Need help with ICD-10 coding for Secondary Lung Cancer? Ask your questions below.

Ask about any ICD-10 CM code, or paste a medical note

We build tools for
clinician happiness.

Learn More at Freed.ai
Back to HomeBeta

Built by Freed

Try Freed for free for 7 days.

Learn more